1315 Capital provides expansion and growth capital to commercial stage pharmaceuticals, medical technologies, and healthcare services.
Business Model: B2B
Revenue: $15M
Employees: 11-50
Address: 2929 Walnut Street
City: Philadelphia
State: PA
Zip: 19104
Country: US
1315 Capital provides expansion and growth capital to commercial-stage specialty pharmaceutical, medical technology, and healthcare services companies, the latter including businesses focused on cost containment and digital health. We believe that these investment areas are attractive largely due to numerous niche market sub-segments and business models where high-quality management teams can rapidly grow small platform companies, in a capital efficient way, into large and important businesses. The firm targets $10-$20 million investments in commercial healthcare entities that have the potential to scale to approximately $100 million of revenue, a highly attractive level for acquisition or to access the public markets.
Contact Phone:
+12156621315
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
9/2021 | Onkos Surgical | Series C | 22.5M |
4/2017 | Onkos Surgical | Series B | 17.6M |
10/2015 | Onkos Surgical | Series A | - |
7/2022 | NutriSense | Series A | 25M |
7/2017 | Colorescience | Series C | 15M |
10/2015 | JDS Therapeutics LLC | Private Equity Round | 0 |
11/2017 | Misonix | Post-IPO Equity | 0 |
4/2019 | Encore Dermatology | Debt Financing | 20M |
7/2022 | NutriSense | Series A | 0 |
9/2021 | Onkos Surgical | Series C | 0 |
4/2019 | Encore Dermatology | Debt Financing | 0 |
11/2017 | Misonix | Post-IPO Equity | 0 |
7/2017 | Colorescience | Series C | 0 |
4/2017 | Onkos Surgical | Series B | 0 |
10/2015 | JDS Therapeutics LLC | Private Equity Round | 0 |
10/2015 | Onkos Surgical | Series A | - |
Name | Price |
---|
Name | Size | Announced Date |
---|